
Avacta appoints biotech executive and oncologist to bolster strategy
Avacta has appointed Dr Mark Goldberg as Non-executive Director to the Board with immediate effect. Dr Alastair Smith, Chief Executive Officer of Avacta, said Goldberg’s experience as a biotech executive and oncologist will greatly benefit the strategy and vision for the therapeutic business. Dr Goldberg is a medical oncologist and haematologist on the faculty… Read More















